III 111th CONGRESS 2d Session S. RES. 676 IN THE SENATE OF THE UNITED STATES November 15, 2010 Mrs. Shaheen (for herself, Ms. Collins, Mr. Dorgan, Mr. Lautenberg, Mr. Tester, and Mr. Johnson) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions November 29, 2010 Committee discharged; considered and agreed to RESOLUTION Supporting the goals and ideals of American Diabetes Month.

Whereas according to the Centers for Disease Control (referred to in this preamble as the CDC), nearly 24,000,000 people of the United States have diabetes and 57,000,000 people of the United States have pre-diabetes; Whereas diabetes is a serious chronic condition that affects people of every age, race, ethnicity, and income level; Whereas the CDC reports that Hispanic, African, Asian, and Native Americans are disproportionately affected by diabetes and suffer from diabetes at rates that are much higher than the general population; Whereas according to the CDC, 3 people are diagnosed with diabetes every minute; Whereas each day, approximately 4,384 people are diagnosed with diabetes; Whereas in 2007, the CDC estimates that approximately 1,600,000 individuals aged 20 and older were newly diagnosed with diabetes; Whereas a joint National Institutes of Health and CDC study found that approximately 15,000 youth in the United States are diagnosed with type 1 diabetes annually and approximately 3,700 youth are diagnosed with type 2 diabetes annually; Whereas according to the CDC, between 1980 and 2007, diabetes prevalence in the United States increased by more than 300 percent; Whereas the CDC reports that over 24 percent of individuals with diabetes are undiagnosed, a decrease from 30 percent in 2005; Whereas the National Diabetes Fact Sheet issued by the CDC states that more than 10 percent of adults of the United States and 23.1 percent of people of the United States age 60 and older have diabetes; Whereas the CDC estimates that 1 in 3 people of the United States born in the year 2000 will develop diabetes in the lifetime of that individual; Whereas the CDC estimates that 1 in 2 Hispanic, African, Asian, and Native Americans born in the year 2000 will develop diabetes in the lifetime of that individual; Whereas according to the American Diabetes Association, in 2007, the total cost of diagnosed diabetes in the United States was $174,000,000,000, and 1 in 10 dollars spent on health care was attributed to diabetes and its complications; Whereas according to a Lewin Group study, in 2007, the total cost of diabetes (including both diagnosed and undiagnosed diabetes, pre-diabetes, and gestational diabetes) was $218,000,000,000; Whereas a Mathematica Policy study found that, for each fiscal year, total expenditures for Medicare beneficiaries with diabetes comprise 32.7 percent of the Medicare budget; Whereas according to the CDC, diabetes was the seventh leading cause of death in 2007 and contributed to the deaths of over 230,000 Americans in 2005; Whereas there is not yet a cure for diabetes; Whereas there are proven means to reduce the incidence of, and delay the onset of, type 2 diabetes; Whereas with the proper management and treatment, people with diabetes live healthy, productive lives; and Whereas American Diabetes Month is celebrated in November: Now, therefore, be it

That the Senate— (1)supports the goals and ideals of American Diabetes Month, including— (A)encouraging the people of the United States to fight diabetes through public awareness about prevention and treatment options; and (B)increasing education about the disease; (2)recognizes the importance of early detection of diabetes, awareness of the symptoms of diabetes, and the risk factors that often lead to the development of diabetes, including— (A)being over the age of 45; (B)having a specific racial and ethnic background; (C)being overweight; (D)having a low level of physical activity level; (E)having high blood pressure; and (F)having a family history of diabetes or a history of diabetes during pregnancy; and (3)supports decreasing the prevalence of type 1, type 2, and gestational diabetes in the United States through increased research, treatment, and prevention.